81 / 112
79
WFSBP 2015
Thursday, 18 June 2015
|
Scientific Programme
ES-03
Educational Session
09:00–13:00
MC 3.3 Room
Session 3 on brain stimulation methods
Chair:
Mark George, USA
Co-Chair: Shirley Fecteau, Canada
ES-03-001
TDCS (transcranial Direct Current Stimulation) and TMS
(repetitive Transcranial Magnetic Stimulation)
Shirley Fecteau, Canada
Jerome Brunelin, France
Emmanuel Poulet, France
Zafiris J. Daskalakis, Canada
ES-03-002
Deep brain stimulation
Thomas Schlaepfer, Germany
ES-03-003
ECT (electroconvulsive therapy)
Mark George, USA
FC-19
Free Communications
08:30–10:00
Conference Room 1
Anxiety Disorders
Chair:
Soraya Seedat, South Africa
Co-Chair: Ioannis Papakostas, Greece
FC-19-002
Sex differences in kappa opioid receptor-mediated negative
affective states in rats
Maria Mavrikaki, USA
J. Mays, D. Puttick, E. Chartoff
FC-19-003
Mitochondria as pharmacological targets for anxiolytic
treatment
Michaela Filiou, Germany
M. Nussbaumer, L. Teplytska, M. Murphy, R. Landgraf, C. Turck
FC-19-004
A month and 10-year follow-up ptsd study of children
exposed to a mass shooting incident
Ruby Castilla-Puentes, USA
T. Falcone, S. Castilla-Puentes, W. Castilla-Puentes, C. San-
chez-Russi, I. Gomez Morad, M. Habeych
FC-19-005
Molecular alterations in neuronal plasticity, immune re-
sponse, and apoptosis in posttraumatic stress disorder
Anna Boyajyan, Armenia
D. Avetyan, L. Hovhannisyan, G. Mkrtchyan
FC-19-006
The cumulative effect of childhood trauma on adult mental
and physical health: Results from the Marine Resiliency
Study
Agorastos Agorastos, Germany
J. O. E. Pittman, A. C. Angkaw, C. M. Nievergelt, S. A. Parisi,
D. G. Baker
FC-19-007
The role of increased CRP levels and CRP genetic variation
in PTSD
Vasiliki Michopoulos, USA
T. Jovanovic, K. Ressler
FC-20
Free Communications
13:00–14:30
Mitropoulos Hall
Schizophrenia
Chair:
Janusz Rybakowski, Poland
Co-Chair: Elias Angelopoulos, Greece
FC-20-001
A longitudinal study evaluating social cognition of patients
with schizophrenia during the symptomatic and remission
phases
Vijaya Lakshmi, India
R. Nehra, S. Grover
FC-20-002
Meta-analysis of cognitive performance in drug-naïve pa-
tients with schizophrenia
Helena Fatouros-Bergman, Sweden
S. Cervenka, L. Flyckt, G. Edman, L. Farde
FC-20-004
Treatment of neurocognitive dysfunction in schizophrenia:
Effects of atypical antipsychotics on emotion processing
Gabriele Sachs, Austria
A. Erfurth
FC-20-005
Cognitive function in schizophrenia and its association with
socio-demographics factors
Bharti Talreja, India
S. Shah, L. Kataria
FC-20-006
The impact of genetic counselling for severe mental disor-
ders: A meta-analysis
Ramona Moldovan, Romania
D. Cozman, R. Popp, V. Pop, J. Austin